Abstract
We performed a real-life observation of patients with Parkinson disease (PD) who received duodenal levodopa infusion (DLI) to determine which adverse events caused treatment discontinuation and when such events occurred.
| Original language | English |
|---|---|
| Pages (from-to) | 1669-1672 |
| Number of pages | 4 |
| Journal | Neurology |
| Volume | 84 |
| DOIs | |
| Publication status | Published - 2015 |
Keywords
- Parkinson disease
Fingerprint
Dive into the research topics of 'Causes of withdrawal of duodenal levodopa infusion in advanced Parkinson disease'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver